Roy D. Baynes, M.D., Ph.D.

Roy D. Baynes, M.D., Ph.D.

DirectoratAardvark Therapeutics· In proxies 2023–2025

Roy D. Baynes, M.D., Ph.D. sits on 9 public boards.

Boards2

  • Travere TherapeuticsDirector · 9 yr on the boardIndependentCorporate Governance, Science and Medical Technology (Chair)—Paid as an executive
  • Aardvark TherapeuticsDirector · 1 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Aardvark TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role -89%
  2. Nurix TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Travere TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. NateraPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  5. Aardvark Therapeutics, Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  6. Adcendo ApSPublic company
    • Director? – PresentNo stock prices for these years
  7. CatalYm GmbHPublic company
    • Director? – PresentNo stock prices for these years
  8. Atara Biotherapeutics, Inc.Public company · 4 yr
    • Director2018 – 2022 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?